CAB/ESCRO

SARS-CoV-2 or COVID-19 Related Research

You must let your Biosafety Officer know of ANY SARS-CoV-2 or COVID-19 related research you are planning to perform. Research involving recombinant parts of SARS-CoV-2, SARS-CoV (also referred to as SARS-CoV-1), or MERS-CoV requires registration with the CAB/ESCRO (MIT Committee on Assessment of Biohazards & Embryonic Stem Cell Research Oversight). Samples containing SARS-CoV-2, such as cultures obtained from collaborators samples from COVID-19 patients or samples suspected to contain SARS-CoV-2, must be inactivated before arriving at MIT and need to be registered with the CAB/ESCRO even if already inactivated. The Committee will review the inactivation procedure and determine if the samples can be used at MIT. Please plan accordingly and email BSP@mit.edu for a proper risk assessment.